| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evofem Biosciences, Inc. | Chief Financial Officer | Common Stock | 24,065 | $927 | $0.0385 | 31 Dec 2022 | Direct |
| Lite Strategy, Inc. | CEO, CFO and Secretary, Director | Stock Option (Right to Buy) | 180,000 | 14 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MEIP | Lite Strategy, Inc. | 14 Nov 2025 | 1 | $0 | 4/A | CEO, CFO and Secretary, Director | 20 Nov 2025, 17:29 |
| MEIP | MEI Pharma, Inc. | 15 Jul 2025 | 1 | $0 | 4 | Secretary, Acting CEO & CFO | 17 Jul 2025, 21:36 |
| MEIP | MEI Pharma, Inc. | 12 Jun 2023 | 0 | $0 | 3 | CFO and Corporate Secretary | 01 Aug 2023, 19:07 |
| EVFM | Evofem Biosciences, Inc. | 31 Dec 2022 | 1 | $0 | 5 | Chief Financial Officer | 08 May 2023, 16:05 |
| EVFM | Evofem Biosciences, Inc. | 18 Feb 2022 | 2 | $0 | 4 | Chief Financial Officer | 23 Feb 2022, 15:06 |
| EVFM | Evofem Biosciences, Inc. | 31 Dec 2021 | 1 | $0 | 4 | Chief Financial Officer | 04 Jan 2022, 15:05 |
| EVFM | Evofem Biosciences, Inc. | 20 Dec 2021 | 1 | +$15,020 | 4 | Chief Financial Officer | 20 Dec 2021, 15:20 |
| EVFM | Evofem Biosciences, Inc. | 10 Jun 2021 | 1 | +$25,235 | 4 | Chief Financial Officer | 10 Jun 2021, 19:30 |
| EVFM | Evofem Biosciences, Inc. | 20 May 2021 | 1 | -$36,361 | 4 | Chief Financial Officer | 21 May 2021, 16:25 |